DEARhealth
DEARhealth is a Dutch-American healthcare spin-out from the University of California, Los Angeles , founded in 2013 by gastroenterologists Daniel Hommes and Eric Esrailian.
The company develops artificial intelligence-powered, personalized care pathways for chronic care. The platform supports Value Based Health Care and aims to get the best outcomes for patients and providers, optimizing a value quotient, defined as patient value/provider costs. Treatment areas include inflammatory bowel disease, pain management, liver diseases, ovarian cancer, chronic kidney diseases, low back pain and epilepsy.History
In 2012 DEARhealth started as a research project at UCLA. In 2013 DEARhealth was founded as a company. In June 2019 DEARhealth announced collaboration outside UCLA with UCB on epilepsy. In July 2019, the company closed a series A funding round led by Philips.
